Technical Analysis for NWPHF - Newron Pharms Spa Ord

Grade Last Price % Change Price Change
C 2.8 -6.67% -0.2000
NWPHF closed down 6.67 percent on Monday, April 12, 2021, on 25 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical NWPHF trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -6.67%
Stochastic Reached Overbought Strength -6.67%
Wide Bands Range Expansion -6.67%
Above Upper BB Strength -6.67%
Overbought Stochastic Strength -6.67%
Older End-of-Day Signals for NWPHF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its pipeline of products include Sarizotan for patients with Rett syndrome; Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Psychoactive Drugs Pain Medication Stage Biopharmaceutical Parkinson's Disease Treatment Of Parkinson's Disease Schizophrenia Peripheral Nervous System Rett Syndrome Safinamide

Is NWPHF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 8.9
52 Week Low 1.801
Average Volume 4,050
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 2.2818
10-Day Moving Average 2.4174
Average True Range 0.6499
ADX 0.0
+DI 17.2546
-DI 78.4507
Chandelier Exit (Long, 3 ATRs ) 6.1503
Chandelier Exit (Short, 3 ATRs ) 3.7507
Upper Bollinger Band 3.0610
Lower Bollinger Band 1.5026
Percent B (%b) 0.83
BandWidth 68.2970
MACD Line -0.3437
MACD Signal Line -0.3908
MACD Histogram 0.0471
Fundamentals Value
Market Cap 49.97 Million
Num Shares 17.8 Million
EPS
Price-to-Sales 4.02
Price-to-Book 1.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.8000
Resistance 3 (R3) 2.8000 2.8000 2.8000
Resistance 2 (R2) 2.8000 2.8000 2.8000 2.8000
Resistance 1 (R1) 2.8000 2.8000 2.8000 2.8000 2.8000
Pivot Point 2.8000 2.8000 2.8000 2.8000 2.8000
Support 1 (S1) 2.8000 2.8000 2.8000 2.8000 2.8000
Support 2 (S2) 2.8000 2.8000 2.8000 2.8000
Support 3 (S3) 2.8000 2.8000 2.8000
Support 4 (S4) 2.8000